Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotech VC Funds in Japan

Last updated: Apr 2024 A list of 50 VC funds that invest in Biotech startups based in Japan. We rank investors based on the number of investments they made in Biotech companies from Japan. We update this investor list every month.

Top 50 Biotech VC Funds in Japan

Investor	Biotech Japan investments
Mitsubishi UFJ Capital	14
Osaka University Venture Capital	13
ANRI	9
Real Tech Japan	9
SMBC Venture Capital	8
Fast Track Initiative, Inc.	7
Mizuho Capital	6
Nissay Capital	6
SBI Investment	6
Nippon Venture Capital	5
DBJ Capital	5
Keio Innovation Initiative	5
Japan Science and Technology Agency	5
Real Tech Holdings	4
Remiges Ventures	4
F-Prime Capital	4
Incubate Fund	4
Senshu Ikeda Capital	3
Takeda Ventures	3
Takeda	3
Future Venture Capital	3
KSP	3
JIC Venture Growth Investments	3
Eight Roads Ventures	3
Ohara Pharmaceutical	2
Tsukuba Institute of Research	2
Primal Capital	2
SBI Group	2
UTokyo Innovation Platform	2
ITOCHU Technology Ventures	2
Glocalink	2
Essential Pharma	2
SPARX Group	2
Capital Medica Ventures	2
Media Future	2
Fujifilm	2
Japanese Organization for Medical Device Development	2
Japan Asia Investment	2
Kyogin Lease & Capital	2
Fuyo General Lease	2
Innovation Network Corporation of Japan	2
FFG Venture Business Partners	2
Tokyo Century	2
Triple Ring Technologies	1
Nexyz.Group	1
Daiichi Sankyo	1
CAC CAPITAL	1
CareNet	1
Energy & Environment Investment	1
NEC Capital Solutions	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Investment focus

Information Technology, Software, Health Care
Funding Round, Series B, Series A
Japan, United States, China

Portfolio highlights

Parallel — Parallel Inc. develops a parallel SNS which can be used while playing games on smartphones.
Swell — Swell is an information technology company that specializes in providing web and digital platforms.
GenerativeX Co — GenerativeX provides AI app development, consulting, and generative model development.

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Investment focus

Biotechnology, Health Care, Manufacturing
Funding Round, Seed, Series A
Japan

Portfolio highlights

EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
Thinker — Thinker provides sales of proximity sensors and proposed solutions using these products.
Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Series A
Japan, United States, India

Portfolio highlights

MOVeLOT — MOVeLOT is an AI company that provides skeletal platform and robot planning, development, and production services.
xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
Infobox — Infobox is a sales data platform that includes every detail from market research to creating a list of companies and contacting decision-makers.

Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.

Investment focus

Manufacturing, Biotechnology, Robotics
Funding Round, Series A, Seed
Japan, Singapore, Austria

Portfolio highlights

Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
ProfilePrint — Helping agribusinesses buy and sell better, ProfilePrint is powered by a patented digital food identity-as-a-service (IDaaS) technology. ProfilePrint synthesises complex molecular data of ingredient samples into digital fingerprints, rapidly predicting its identity and quality.
Integriculture — Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable cleanmeat.Founded in 2015, Integriculture is headquartered in Tokyo, Japan.

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Investment focus

Information Technology, Health Care, Software
Funding Round, Series B, Series A
Japan, United States, Mexico

Portfolio highlights

Ababa — Ababa provides recruitment and employment solutions.
HarvestX — HarvestX manufactures fully automatic robots which contributes to the shortage of agricultural human resources and stable food production
Smartpay — Smartpay is the first free of charge BNPL payment option for Japanese consumers who have credit cards. There are no sign-up fees, interest fees, settlement fees, or late charges. The payment experience is also Japan’s first cross-merchant, cross-platform, and single-click checkout BNPL service, allowing consumers to checkout in as little as 10seconds. The BNPL payment solution is simple to understand, structured on 3 equal installments over 8 weeks. This means that unlike the existing BNPL services in Japan, customers do not need to go to the convenience store to make payments or pay any bank transfer fees.

Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.

Investment focus

Health Care, Biotechnology, Medical
Funding Round, Series B, Series A
Japan, United States, United Kingdom

Portfolio highlights

AIRNA — AIRNA is on a mission to transform the lives of patients with rare and common diseases by pioneering thediscovery and development of RNA editing therapeutics.
Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.

Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.

Investment focus

Information Technology, Software, Internet
Funding Round, Series A, Series B
Japan, United States, China

Portfolio highlights

Japan DX — Japan DX platform provides a comprehensive data-driven services to inbound tourists to Japan.
Unito — Unito offers people a friction-free lifestyle by pursuing optimization of living.
GenerativeX Co — GenerativeX provides AI app development, consulting, and generative model development.

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Investment focus

Health Care, Internet, Medical
Funding Round, Seed, Series A
Japan, United States

Portfolio highlights

Dodai — Dodai manufactures and assembles the electric motorcycles.
Yap — Yap helps pharmaceutical businesses enter the market in a multitude of methods.
Pocket Sign — Pocket Sign develops digital platforms that store e-signatures and other authentication details for it's users privacy and security.

SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.

Investment focus

Financial Services, Software, Information Technology
Series B, Funding Round, Series A
Japan, South Korea, United States

Portfolio highlights

Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
TopoLogic — TopoLogic designs and manufactures heat flow sensors, thermoelectric conversion devices, and topological and novel spintronics materials.
OPTEMO — OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Investment focus

Software, Health Care, Information Technology
Funding Round, Series A, Seed
Japan, United States

Portfolio highlights

Issues — Issues provides development and management of web service issues that solve the problems.
Trustart — Trustart engages in real estate research business and real estate big data provision. The company offers real estate big data and big data subscriptions.
LIFESCAPES — LIFESCAPES is a research and manufacturer of brain-computer interface equipment.

DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.

Investment focus

Software, Internet, Biotechnology
Funding Round, Series A, Seed
Japan, United States, Australia

Portfolio highlights

Cellusion — Cellular technology breakthrough for clear vision of the future.
Hedgehog MedTech — Hedgehog Medtech is a medical firm focused on digital therapeutics (DTx). DTx is a pharmaceutically approved programmable medical device that assists patients' medical operations via smartphone apps.
Kyoto Fusioneering — Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors.

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Investment focus

Medical, Health Care, Biotechnology
Funding Round, Seed, Series A
Japan

Portfolio highlights

newmo — newmo delivers sustainable local public transportation create a user experience (UX) that people may utilize with peace of mind and comfort.
Axelspace — Axelspace is a startup company developing businesses in the microsatellite field. Axelspace plans to construct a monitoring platform to cover the entire globe on a daily basis at extremely low cost.
Hedgehog MedTech — Hedgehog Medtech is a medical firm focused on digital therapeutics (DTx). DTx is a pharmaceutically approved programmable medical device that assists patients' medical operations via smartphone apps.

Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.

Investment focus

Medical, Biotechnology, Health Care
Funding Round, Series A, Series B
Japan

Portfolio highlights

QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
bitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.

Real Tech Holdings is an R&D-based innovative technology that specializes in social implementation.

Investment focus

Manufacturing, Aquaculture, Biotechnology
Seed, Series A, Funding Round
Japan, Singapore, India

Portfolio highlights

CellFiber — Cell fiber technology was developed as a basic technology for handling cells in the engineering field.
Eight Knot — Eight Knot designs and develops autonomous navigation system for water mobility using robotics & AI.
Tokyo Nucleic Acid Synthesis — Tokyo Nucleic Acid Synthesis is a pharmaceutical company that focuses on developing nucleic acid drugs using new-age medical technology.

Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Japan, Canada

Portfolio highlights

Immunis — Currently seeking participants for age-related muscle atrophy (sarcopenia) clinical trails
Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.

F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
United States, United Kingdom, China

Portfolio highlights

HiLabs — A Monetizable Artificial Intelligence Platform
Dispatch — OneAdvisory helps independent financial advisors to build ideal firms through strategic investments and advanced technology. The company was founded in 2022 and is headquartered in Miami, Florida.
Comanche Biopharma — Comanche Biopharma is a biopharmaceutical company that develops siRNA therapy for the treatment of preeclampsia. The company aims to lower the risks of pregnancy and prematurity by safely sustaining natural pregnancy and allowing fetal maturation.

Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.

Investment focus

Software, E-Commerce, Information Technology
Seed, Funding Round, Series A
Japan, United States, India

Portfolio highlights

SoftRoid — SoftRoid provides a software robot that patrols and collects data for analyzing the construction site.
M-INT — M-INT is a life science company that offers medical infrastructure and medical IT system.
Blossom Energy — Developed advanced nuclear reactors that are able to produce clean energy, Blossom Energy manufactures nuclear reactors for the nuclear energy industry. The focus of the company is on providing affordable, stable, and sustainable energy for the world. The company utilizes HTGR, which is a fourth-generation nuclear reactor.

Senshu Ikeda Capital offers financial consultancy services.

Investment focus

Software, Internet, Information Technology
Funding Round, Seed, Series A
Japan

Portfolio highlights

Sagri — Sagri is developing agriculture software for experienced farmers.
BABY JOB — BABY JOB offers nursery support and child care support businesses.
On The Slope — On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.

Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Corporate Round, Funding Round, Series A
United States, Japan, Canada

Portfolio highlights

Ambys Medicines — Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies. Ambys Medicines is working to fundamentally transform the lives of people suffering from severe liver diseases by creating breakthrough therapies capable of restoring liver function, preventing the progression of liver disease,and treating the devastating complications of liver failure.
Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Cardurion Pharmaceuticals — A Boston-based cardiovascular biotechnology company developing next-generation therapeutics for the treatment of heart failure and cardiovascular diseases.

Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.

Investment focus

Information Technology, Manufacturing, Health Care
Funding Round, Seed, Series A
Japan, United States, Myanmar

Portfolio highlights

My Salon — My Salon is an AI cosmetics recommendation service that provides skin care services.
Peco Free — Peco Free is a school meal pre-order service that is selected using a smartphone.
Thinker — Thinker provides sales of proximity sensors and proposed solutions using these products.

KSP, Inc. is the core business entity responsible for operating the Kanagawa Science Park (KSP) and has accepted the challenge of creating new industries through the support, development, and incubation of venture businesses. We provide a variety of business support services that best meet the needs of venture businesses in each stage of theirbusiness growth, ranging from the processes of startup and growth to public offerings. Several hundreds of new startup companies have been created and nurtured since its foundation. An incubation manager (IM) acts as a coordinator and provides a variety of support services to a venture company to help them successfully launch and develop their new business, such as offering individual consultations and a variety of information or advice. KSP, Inc. is well poised to cope with the varying needs of new ventures for highly sophisticated, specialized tasks by offering a business school, business support center, business matching services, and investment funds.The public sector, such as the Kanagawa prefectural government, Kawasaki city government, and the Development Bank of Japan, Inc., has an equity participation in KSP, thus playing a vital role in the deployment of local industrial development policy.

Investment focus

Biotechnology, Health Care, Medical
Funding Round, Series A, Series B
Japan

Portfolio highlights

Metcela — Metcela Inc. is a pioneer biotechnology company founded in Japan. Metcela aims to be the first to commercialize biological products that heal damaged heart muscle to treat heart failure.
Mira Robotics — I found a great domain name for sale on Dan.com. Check it out!
Melody International Japan — Melody International Japan is a company that supports medical and health with ICT.

JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses.JIC Venture Growth Investments was established in July 2020 and isbased in Tokyo, Japan.

Investment focus

Software, Information Technology, Consulting
Series B, Series C, Funding Round
Japan, Singapore, Thailand

Portfolio highlights

LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
Gaianixx — Gaianixx is a manufacturing company that conducts research and develops new technologies to advance the semiconductor sector.
Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

Investment focus

Software, Health Care, Information Technology
Series B, Series A, Series C
United States, China, India

Portfolio highlights

HiLabs — A Monetizable Artificial Intelligence Platform
EurekaBio — EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
Shadowfax — Best last mile delivery service provider across Food, E-commerce, Groceries, Pharma, FMCG, Consumer durables, Auto, BFSI, Telecom, Freight forwarding & Apparel.

Ohara Pharmaceuticals is a pharmaceutical business involved in the development, manufacture, and distribution of pharmaceutical products.

Investment focus

Medical, Biotechnology, Nursing and Residential Care
Series A, Funding Round, Series B
Japan, Kenya, Nigeria

Portfolio highlights

HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
Helium Health — Helium Health empowers healthcare providers in Africa with digital tools, financing solutions, and data partnerships. Learn more about our innovative solutions.
Revital Healthcare — Revital Healthcare is a manufacturer of medical devices and disposables for hospitals and other medical laboratories. It offers single-use syringes, needles, re-use prevention syringes and auto-disable syringes which helps in reducing the transmission of HIV and other blood-borne diseases along with infusion sets, blood transfusion sets and bloodcollection tubesThe company was established in 2006 and is headquartered in Kilifi, Kenya.

Tsukuba Institute of Research (筑波総研) is an R&D center owned by housing and wood products group Sumitomo Forestry. The facility develops technologies to make more effective use of wood in a wide range of fields.

Investment focus

Biotechnology, Medical, Manufacturing
Funding Round, Series A, Seed
Japan

Portfolio highlights

LIGHTz — LIGHTz delivers a technology transfer and information exchange platform leveraging AI.
Alchemedicine — Alchemedicine is a the world in drug discovery with unique technologies and ideas Innovating new drug candidates for diseases with high unmet medical needs.
Veneno Technologies — Veneno Technologies engages in the research and development of therapeutic disulfide-rich peptides and contribute to advanced medicine.

Primal Capital, an independent venture capital " incubator bait fund at ", served as the Associate than July 2012 Hiroshi was Sasaki is the venture capital fund that serves as the representative partner. Representative of Sasaki, the seed acceleration program "Incubate Camp" operated by Incubate bait fund is carried out a totalof four times of planning and management than in 2012, They have also engaged in support operations of portfolio companies. - See more at: https://www.crunchbase.com/organization/primal-capital#sthash.m2z1DCbt.dpuf

Investment focus

Software, Internet, Task Management
Seed, Funding Round, Pre-Seed
Japan, Spain, Switzerland

Portfolio highlights

Rand App — Rand is a fintech firm that offers banking services, savings, deposits, and account opening.
Degas — Degas develops solutions to improve the productivity of small-scale farmers in Africa.
xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.

SBI Group aims to become a corporate entity that provides a variety of one-stop financial services over the Internet now that two major events, the Financial Big Bang resulting from deregulation, and the Internet Revolution resulting from IT innovation, have radically transformed the financial industry.

Investment focus

Financial Services, FinTech, Information Technology
Series B, Series A, Funding Round
Japan, United States, United Kingdom

Portfolio highlights

Etaily — Etaily provides complete end-to-end omni-channel eCommerce services to ensure brands will successfully thrive in the digital economy
Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
BLOCKSMITH&Co — BLOCKSMITH&Co. is developing and distributing of Game&SocialFi services such as blockchain technology, crypto assets and virtual currency utilising NFTs on the Web3

The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.

Investment focus

Biotechnology, Medical, Health Care
Series A, Funding Round, Seed
Japan, United States, United Kingdom

Portfolio highlights

Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
Yoii Fuel — Yoii Fuel is a software company which analyzes a company's KPIs and enables them to obtain a means of financing based on this data.
Better Place — Better place vision is to create a world in which kind people can continue to be kind, as well as a society in which people can work in their own way without worrying about money.

ITOCHU Technology Ventures (ITV), based in Tokyo, is the venture capital arm of ITOCHU Corporation. ITOCHU is one of the world's largest corporations with offices in over 80 countries and operations that cover a broad spectrum of industries. ITV's mission is to invest and help build leading information technology companies by leveraging avast array of resources both domestically and internationally throughout ITOCHU and its group companies. The ITOCHU group has a long history of funding information technology companies with successes including Siebel Systems, NVIDIA, Openwave and Aruba Networks. Current portfolio includes, Box, Fab, Ooyala, WHILL, Tokyo Otaku Mode, etc.

Investment focus

E-Commerce, Software, Information Technology
Funding Round, Series B, Series A
Japan, United States, Belgium

Portfolio highlights

Funds — Funds is an online marketplace for lending funds.
KAICO — KAICO is a pharmaceuticals, diagnostic drugs production company.
Yoii Fuel — Yoii Fuel is a software company which analyzes a company's KPIs and enables them to obtain a means of financing based on this data.

Glocalink provides seed funding and comprehensive support for emerging science & technology entrepreneurs. Members of Glocalink have extensive experiences of bringing laboratory technologies to the market. On top of seed funding, we will provide comprehensive supports for overcoming all the hurdles that science / technology entrepreneursface.

Investment focus

Health Care, Robotics, Task Management
Funding Round, Seed, Series A
Japan, Singapore

Portfolio highlights

MOVeLOT — MOVeLOT is an AI company that provides skeletal platform and robot planning, development, and production services.
ExtraBold — ExtraBold specializes in the development of 3D printers.
ProfilePrint — Helping agribusinesses buy and sell better, ProfilePrint is powered by a patented digital food identity-as-a-service (IDaaS) technology. ProfilePrint synthesises complex molecular data of ingredient samples into digital fingerprints, rapidly predicting its identity and quality.

Essential Pharma provided on this site is created for the purpose of providing information on our ethical drugs to medical professionals

Investment focus

Medical, Biotechnology, Genetics
Series A, Funding Round
Japan

Portfolio highlights

HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
HekaBio — HekaBio connects world-leading healthcare innovations to unmet medical needs in the Asia Pacific, with broad category development expertise in pharma, medical device, in-vitro diagnostics, digital health, and cell & gene therapies.
Jiksak Bioengineering — Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).

SPARX Group Co., Ltd. is an independent Asia-based equity and credit asset management services and Asian fund financial specialist with offices in Tokyo, Hong Kong and Seoul for global institutional and individual investors, including financial advisors and financial planners, with alternative strategies (including activist, short-enabled, private equity and quantitative and fund-of-funds) and mutual funds (through SPARX Asia Funds such as SPARX Asia Pacific Opportunities Fund, SPARX Asia Pacific Equity Income Fund, SPARX Japan Smaller Companies Fund and SPARX Japan Fund) managed or sub-advised by SPARX Asset Management Co. Ltd., SPARX Asia Investment Advisors Limited and Cosmo Asset Management Co., Ltd.

Investment focus

Software, Artificial Intelligence, Information Technology
Funding Round, Series B, Series A
Japan, United States, China

Portfolio highlights

Blue Laser Fusion — Blue Laser Fusion is a commercial fusion company. Blue Laser Fusion is a laser startup to commercialize laser fusion by inventing its own laser and fusion reactor.
UnaBiz — Based in Singapore, Taiwan and Japan, UnaBiz delivers end-to-end customised IoT solutions worldwide. Simple, cost-efficient & low maintenance
Nanofiber Quantum Technologies — Powering a globally connected quantum future with pioneering nanofiber cavity QED.

Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.

Investment focus

Medical, Software, Health Care
Seed, Series A, Funding Round
Japan

Portfolio highlights

HCMJ — HCMJ specializes in software development in the medical industry.
Epigno — Epigno provides hospital management systems for medical institutions.
Rehab — Rehab for Japan is developing a special rehabilitation SaaS for day service .

Media Future is a group of communication technology professionals that works on connecting feelings and thoughts. The Tokyo, Tokyo-based company was established in 2013.

Investment focus

Medical, Biotechnology, Genetics
Series A, Funding Round
Japan

Portfolio highlights

HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
HekaBio — HekaBio connects world-leading healthcare innovations to unmet medical needs in the Asia Pacific, with broad category development expertise in pharma, medical device, in-vitro diagnostics, digital health, and cell & gene therapies.
Jiksak Bioengineering — Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).

Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.

Investment focus

Biotechnology, Medical Device, Medical
Series A, Funding Round, Series B
Japan, Israel, United States

Portfolio highlights

Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Nanox Imaging — Nanox Vision develops a next-generation medical imaging system based on groundbreaking technology. Our aim is to democratize medical imaging and bring preventive healthcare to communities worldwide, helping create a better standard of care for all.
24M Technologies — 24M Technologies develops energy storage systems for grid and transportation applications. 24M Technologies, Inc. builds energy storage systems for grid and transportation applications. The company was founded in 2010 and is based in Cambridge, Massachusetts.

The Japan Medical Device Development Organization aims to activate Japan's medical innovation and medical device industry, centering on the medical device incubation business, and aim for Japan to become a world leader in this field.Japanese Organization for Medical Device Development is a country of craftsmanship, possesses high technicaland quality control skills, and should be good at producing medical equipment. However, in the medical device field, imports exceed 600 billion yen every year. Japan's “manufacturing” technology has not been fully utilized.

Investment focus

Biotechnology, Laser, Medical
Seed, Series A, Funding Round
Japan, United States

Portfolio highlights

Luxonus — Luxonus is a product development of a new imaging device using optical ultrasonic technology.
Meltin MMI — Meltin MMI is a cyborg-technology company that focuses on biosensors and robotic arms. Meltin has successfully enabled fine finger movements, such as for amputees and participated in Cybathlon 2016 and won the Microsoft Innovation Award.
Genomelink — Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others.

JAIC is Japan's largest independent venture capital firm and has accumulated experience and know-how over a period of 15 years as a pioneer of venture capital investments in Asia. Building on such strengths, they are establishing a globally linked organization that pursues investment opportunities centering on the three regions of Japan, Asia,and the United States.

Investment focus

Medical, Biotechnology, Health Care
Series B, Funding Round, Series C
Japan, United States, China

Portfolio highlights

FacePeer — FacePeer is looking for people who want to challenge at startup.
REGiMMUNE — REGiMMUNE Corporation is a private biopharmaceutical company developing innovative solutions for treating immune disorders caused by nonspecific and/or excessive immune reactions. REGiMMUNE uses its proprietary technology platform, reVax (reverse vaccination), to target immune tolerance against specific disease-causing antigens throughinduction of regulatory T cells (Treg). This technology has potential applications in a number of immune system disorders and diseases including Graft versus Host Disease (GvHD), type 1 diabetes mellitus (T1DM), rheumatoid arthritis (RA), multiple sclerosis (MS) and systemic lupus erythematosus (SLE).Currently, the company has one clinical-stage compound in a Phase I/II trial in the United States (RGI-2001) as a treatment for GvHD associated with hematopoietic stem cell transplantation and has a second product in preclinical development (RGI-3001) as a new treatment for T1DM. In addition, it has a number of well-differentiated compounds in its research-stage pipeline.In healthy individuals, the normal immune system works to protect humans from disease-causing viruses, bacterium, and cancers; or foreign antigens such as peanuts, wheat and tree pollens. Conventional immunosuppressants have several significant side effects associated with long-term administration including risk of infection, toxicity and relapse. Products developed with ReVax technology are expected to reduce or eliminate such side effects as well as reduce long-term treatment.
Integral Geometry Science — Integral Geometry Science is a specialized manufacturer of measuring equipment and signal / image processing software.

Kyogin Lease & Capital is an investment firm that specializes in the leasing, stock and bond investment and public offering consulting.

Investment focus

Manufacturing, Task Management, Medical
Funding Round, Series A, Series B
Japan

Portfolio highlights

Thinca — Thinca is an IT system planning, development, and operations company that provides a cloud-based CTI (Computer Telephony Integration) hospitality & communication solution for corporate offices.
Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.

Fuyo General Lease focuses in the leasing and installment sales trading of equipment and fixtures, and financial transaction. The company provides leasing services of information-related equipment, office equipment, and industrial equipment, installment sales of commercial facilities, production facilities, and hospital facilities. It also providessecurities management services and anonymous association composition.Fuyo General Lease was founded on 1969 and is headquartered in Tokyo, Japan.

Investment focus

Manufacturing, Biotechnology, Sales
Series A, Funding Round, Corporate Round
Japan

Portfolio highlights

Tsubame BHB — Tsubame BHB is a Sales company
A.L.I. Technologies Japan — Site will be available soon. Thank you for your patience!
3D Printing Corporation — 3D Printing Corporation provides 3D printing technology solutions.

Innovation Network Corporation of Japan (INCJ) is a public-private partnership aimed at promoting innovation and enhancing value.Leveraging the rich history of Japanese technological prowess, INCJ aims to provide financial, technological and management support in order to promote the creation of next-generation businesses through “openinnovation,” or the flow of technology and expertise beyond the boundaries of existing organizational structures.INCJ will draw on funding as well as management and technological expertise from the public and private sectors. INCJ is actively reviewing various investment opportunities in areas of green energy, electronics, IT and biotechnology to infrastructure-related sectors such as water supply. Each investment will be thoroughly vetted to ensure it meets the exacting standards of INCJ's Innovation Network Committee, which will make the final investment decisions.INCJ is capitalized at 280 billion yen, with the Japanese government injecting 266 billion yen and 26 private corporations (refer to details in Appendix below) providing a further 14 billion yen. The government will also provide guarantees up to a total of 1,800 billion yen for INCJ investments, giving it an investment capability of approximately 2,000 billion yen. INCJ will be established for a period of 15 years.

Investment focus

Manufacturing, Software, Robotics
Funding Round, Series B, Series A
Japan, United States, United Kingdom

Portfolio highlights

Cloudian — Cloudian provides exabyte-scale storage for your capacity-intensive workloads: S3-compatible storage for on-prem, hybrid cloud, and multi-cloud.
Seajacks — Great Yarmouth based Seajacks owns and operates self-propelled jack-up vessels which safely and efficiently install and maintain offshore wind farms worldwide. Equipped to service the demands of the offshore energy industry, Seajacks Kraken, Leviathan, Hydra, Zaratan and Scylla are all capable of working independently or in tandem. Utilizingdynamic positioning for fast and efficient rig moves, without the use of tugs gives Seajacks year-round operating capability in harsh conditions. Seajacks’ on and offshore crews work in full conjunction with every client, looking to provide the most cost-effective solutions in the safest environments possible.
Vehicle Energy Japan — Vehicle Energy Japan specializes in development, manufacturing and sales of automotive lithium-ion batteries.

FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.

Investment focus

Content, Media and Entertainment, Artificial Intelligence
Series B, Funding Round, Seed
Japan

Portfolio highlights

KAICO — KAICO is a pharmaceuticals, diagnostic drugs production company.
Yoii Fuel — Yoii Fuel is a software company which analyzes a company's KPIs and enables them to obtain a means of financing based on this data.
OPTEMO — OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.

Tokyo Century is a diversified leasing business (leasing, installment sales, and other financial services for IT-related equipment, industrial equipment, and other machinery and facilities). Tokyo Century has various types of financing and is an international business.

Investment focus

Transportation, Internet of Things, Robotics
Funding Round, Series A, Private Equity
Japan, Singapore, United States

Portfolio highlights

KAICO — KAICO is a pharmaceuticals, diagnostic drugs production company.
Spiber Inc. — Established in September 2007, Spiber Inc. is a Japanese biotechnology startup utilizing cutting-edge synthetic biology, polymer, and material science for the development of its novel Brewed Protein™ materials. Produced through microbial fermentation and utilizing agricultural feedstocks as primary raw materials, Brewed Protein™ polymers arewell-positioned to make significant contributions to animal- and plastic-free initiatives in a range of fields such as the apparel and automotive industries. Leveraging its R&D expertise, Spiber pursues its mission of positively contributing to sustainable human well-being. Operation of Spiber’s first mass production plant in Rayong Province, Thailand, is slated to commence within 2021. The company is also constructing a second mass production facility with partner ADM in Iowa, USA, which is scheduled to begin operating in 2023 at the earliest.
Volocopter — Volocopter is here to change air transport and the aviation industry with the its all-electric air taxi. Discover it now!

Triple Ring Technologies is an on-demand core technology and product creation lab serving partners in regulated industries. They have successfully completed over 300 projects for confidential clients. Triple Ring has technology creation facilities in Silicon Valley and Boston.Their headquarters (Newark, CA) is 96,000 sq. ft. of flexible spacethat includes laboratories for electronics, optics, radiation source development, mechanical prototyping; systems integration, client drop-in offices; and pilot manufacturing. They build regulated technologies and complex products and offer a full range of related technical and business services: analysis and creation of intellectual property; development and implementation of technology strategy; design and development of engineering prototypes and released products; feasibility studies and testing; due diligence and situation analysis; and advisory services on regulatory compliance and technology pathways. Above all, they work collaboratively to build novel technologies and products.

Investment focus

Biotechnology, Beauty, Robotics
Seed, Corporate Round
United States, Japan

Portfolio highlights

P-Mind — P-Mind is a research and development of a device that promotes production of sputum neurotrophic factor-like substances. P-Mind aim to establish a non-invasive treatment method using brain cells derived from mouse embryos.
LUUM — LUUM is introducing automation to the beauty-services market, initially focusing on eyelash extensions, a widely popular treatment ($20B global market opportunity). Pioneering a patented combination of robotics, AI, and machine vision, LUUM applies a full set of eyelash extensions in 20 minutes (instead of 2 hours), while eliminating the costsand safety risks associated with human application.
AiM Medical Robotics — We Think in Real Time.

Nexyz.Group provides facility installation service for LED lighting.

Investment focus

Beauty, SNS, Video
Seed, Series A, Series B
Japan

Portfolio highlights

Timee — Timee is a Planning, development and management of Internet media company.
C Channel — C Channel is an online video-based media targeting women aged 20 to 34, focusing on offering lifestyle-related information ranging from hairstyling, food, to travel tips.
DiNA — CLOUD SERVICE SUPPORT

Daiichi Sankyo Company, Limited engages in the research, development, manufacture, import, sale, and marketing of pharmaceutical products. The company offers prescription drugs, OTC drugs, and quasi-drugs. Its principal products include Olmetec, Rezaltas, Calblock, and Mevalotin for cardiovascular diseases; Cravit for infectious diseases; Loxoninfor bone/joint diseases; and Urief for urological diseases. The company also offers vaccines. In addition, the company is developing products for various diseases, which are under various clinical trial stages. Further, it manufactures and sells cosmetics, medical equipment, food, and beverages, as well as veterinary medicines; and manufactures active pharmaceutical ingredients and intermediates. Daiichi Sankyo primarily operates in Japan, North America, Europe, and India. The company is headquartered in Tokyo, Japan.

Investment focus

Medical, Health Care, Therapeutics
Series A, Funding Round
Japan

Portfolio highlights

Cuorips, Inc. — CUORiPS is a company developing new medical care based on world's cutting-edge technology originated in Japan.
SymBio Pharmaceuticals — SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan.

CAC Capital is a multi-strategy corporate venture capital. It pursues absolute fund returns through diversified investments and flexible allocations to venture companies with high growth potential.Supporting the Group's open innovation through means such as support for growth and collaboration of investee venture companies through hands-onin management, marketing, finance, and operations.In addition, aiming to realize high performance as a fund, we will operate a “multi-strategy” type fund that aims to achieve absolute profits by utilizing advanced management strategies and managing and managing portfolios.

Investment focus

Recruiting, Internet of Things, Internet
Series A, Funding Round, Seed
Japan, Malaysia, Thailand

Portfolio highlights

GIZTIX — GIZTIX is an integrated logistics platform, solving problems on speed & fragmented processes of truck sourcing and also managing their own fleets that cause unscalable deliveries. GIZTIX enables businesses to outsource trucks in seconds to they can fulfil deliveries in time and also helping fleet owners to increase efficiency by providing TMSsoftware. Ultimately, GIZTIX will be the winner of trucking market by expanding fleets & customers networks and having largest & most active TRUCKING BIG DATA.
Tsukulink — Tsukulink is a job match matching platform for Japan’s construction industry.
Wired Beans Inc. — Wired Beans Inc. supports basic manufacturing stages using novel information technologies. It was founded on October 13, 2009, and is based in Tokyo, Japan.

CareNet is a marketing company providing various solutions to pharma companies through the management of media specialized in medical/pharmaceutical education for HCPs. For more than 20 years and since its foundation in 1996, CareNet has continually provided places for exchanging therapeutic information, as well as valuable solutions to HCPsand pharmaceutical companies from the position of the No. 1 media in clinical medical education.

Investment focus

Life Science, Biotechnology, Health Care
Series A, Series B, Series C
Japan, United States

Portfolio highlights

Modalis Therapeutics — Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo.
DiscGenics — DiscGenics is focused on developing regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.

Energy & Environment Investment, Inc. (EEI) is Japan’s first venture capital specialized in the clean technology sector. With core members who have rich hands on experience in founding and managing venture companies, we aim to provide risk money and various strategic values to promising venture companies and businesses.

Investment focus

Internet of Things, Software, Energy
Funding Round, Series A, Series B
Japan, United States, Germany

Portfolio highlights

Fager — Fager is an agriculture firm specializing in promoting decarbonization projects, agricultural carbon production, and sales.
Nature — Nature offers a product that enables its users to save money by controlling the use of their air conditioners.The product that the company offers is an air conditioner controller that transforms any window-mounted or through-wall AC into a smart one, equipped with infrared, power control, and sensors that, along with a mobile app for voicesensors, enabling users to operate household appliances with just one smartphone to control their ACs. It transforms the operation of room air conditioners (ACs) to improve comfort and efficiency for consumers while reducing energy demand peaks for utilities with simple, inexpensive, and easy-to-install device.The Boston, Massachusetts-based company was incorporated by Mash Ohtsuka and Haruumi Shiode in 2014.
Synspective — Synspective provides one-stop-solutions by satellite gathered geospatial data. The core technology was developed by the ImPACT program led by The Cabinet Office, Government of Japan, building small SAR satellites and constellations, allowing frequent observation of areas of interest (AOI). Synspective uses its satellites to produce SAR data which can be provided to both government and commercial clients as-is, as well as transform that data through AI solutions to produce insights and user-friendly information across industries.

NEC Capital Solutions Limited provides financial services in Japan. It's Main Business is Leasing for Information and Communication Equipment, Office Equipment, Industrial Equipment and Installment Sales, Business Loans, Factoring Services, Business Outsourcing and Sales of Used Equipment.

Investment focus

Manufacturing, Internet, Artificial Intelligence
Funding Round, Series B, Series A
Japan, United States, Tanzania

Portfolio highlights

GITAI — GITAI is a robotics startup for space development. The company aims to replace astronauts with robots that can work for a long time while being remotely controlled from earth while in low earth orbit space stations to decrease the burden on astronauts, shorten the time it takes to perform work in space, and reduce costs.
Luup — Luup is an Internet Company.
Smart Shopping — Smartmat is an eco-friendly IoT purchase system for on-demand, no-hassle grocery with cost-effective shipping.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate